Ads
-
Related paper
- Status of serine tyrosine kinase at germline and expressional levels in asthma patients
- Effect of Previous Use of Hydroxyurea on the Formation of Response to Tyrosine Kinase Inhibitor Therapy in Patients with Chronic Myeloid Leukemia
- Tyrosine Kinase level and White Blood Cells Count in Untreated and Treated Chronic Myelogenous Leukemia Patients with BCR ABL gene
- Molecular genetic and cytogenetic determinants of primary resistance or loss of the response to treatment with tyrosine kinase inhibitors in patients with chronic myeloid leukemia
- Modern vector in treatment of patients with lung cancer: tyrosine kinase inhibitors in epidermal growth factor receptor mutations (literature review)
- In silico screening of 3,4 dihydropyrimidones as focal adhesion tyrosine kinase inhibitors
- Lung Cancer: Biomarkers, Tyrosine Kinase Inhibitors and Monoclonal Antibodies
- In Silico Molecular Docking Against-KIT Tyrosine Kinase and ADME Studies of 4-Thiazolidinone Derivatives
- CHRONIC MYELOID LEUKEMIA STUDY FOR RESPONSE PATTERN WITH TYROSINE KINASE INHIBITORS
- QSAR APPROACH TO THE STUDY OF THE EGFR TYROSINE KINASE INHIBITORS: THIAZOLYL-PYRAZOLINE DERIVATIVES